Advocacy Partner: National Fabry Disease Foundation
About the National Fabry Disease Foundation
The National Fabry Disease Foundation (NFDF) is an organization dedicated to supporting the Fabry disease community. Our five primary functions are assisting with Fabry disease education, facilitating Fabry disease identification to improve Fabry disease recognition and diagnosis, providing various forms of assistance to individuals with Fabry disease, supporting Fabry disease research, and promoting advocacy for Fabry disease issues.
The NFDF is a non-profit public charity organization under section 501 (c) (3) of the Internal Revenue Service Code.
The NFDF works to increase the level of effort devoted to assisting and supporting people with Fabry disease. While increased effort is required in each of the NFDF’s five primary functions, Fabry disease education and identification are our two highest priorities. It is critically important to educate healthcare providers, families, and others to recognize this progressive, destructive, and often life-threatening disease earlier in the disease process.
Through improved Fabry disease education, family tree analyses, high-risk screening programs, and newborn screening programs, where approved, we must find thousands of individuals in the U.S. living with Fabry disease manifestations who are unaware they have Fabry disease. Once identified and diagnosed, individuals with Fabry disease can make informed disease management and treatment decisions.
With currently available Fabry disease management and treatment options and continued research to discover improved treatments for Fabry disease, many individuals with Fabry disease now have an opportunity to live significantly better and longer lives.
Contact: Jerry Walter – Founder and President
Phone: 919-732-2799 (desk) or 703-298-1935 (cell)
Email: [email protected]
Upcoming events
- There are no upcoming events.
About Advocacy Partners
The information above is provided by our partner. Learn more about our advocacy partners here.
Recent Posts
- Boy with Fabry disease diagnosed with co-occurring blood disorder
- Teva’s Galafold generic for Fabry disease may be available in US
- Less frequent Elfabrio dosing for Fabry disease appears safe, effective
- Fabry disease can’t dampen the adventurous spirit of my kids
- Fabry disease gene therapy study data enough for FDA submission
- Woman, 32, with many symptoms gets Fabry disease diagnosis
- Heart biopsy helped confirm Fabry disease diagnosis in woman, 57
- NORD’s patient assistance programs help cover costs for Fabry patients
- Fabry gene therapy candidate granted FDA’s orphan drug status
- Blood levels of inflammatory proteins higher in Fabry patients